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Positive Selection of a Qa-1-Restricted T Cell
Receptor with Specificity for Insulin
tute for Qdm in the absence of TAP function are not
known.
Qa-1 plays a role in innate immunity as the ligand for
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2000), and it is possible that exchange or competitive
replacement of Qdm with other peptides could result
in enhanced or reduced activation of cells expressing
Summary CD94/NKG2 isoforms.
Qa-1 can also serve as a restriction element for T
The phenotype and development of T cells from trans- cells. Early studies demonstrated that Qa-1 can be rec-
genic mice expressing a T cell receptor with specificity ognized as an alloantigen and that CD8 TCR  CTL
for insulin presented by the MHC class Ib molecule lines with specificity for Qa-1 can be generated in mixed
Qa-1b was investigated. Peripheral T cells from the leukocyte culture after alloimmunization or immuniza-
transgenic mice express CD8 and, after activation, kill tion with spleen cells from H-2 T region congenic donors
Qa-1b-positive lymphoid target cells in the presence (Aldrich et al., 1988; Lindahl et al., 1982). Most Qa-1-
of soluble insulin. Thymic selection requires expres- restricted CTL clones recognize Qdm, although a sub-
sion of Qa-1b but not the dominant Qa-1-associated stantial fraction recognize unknown peptides presented
peptide, Qdm. In contrast to conventional T cells, se- by TAP-deficient cells (Aldrich et al., 1992, 1994; Lowen
lection is at least as efficient when the selecting ligand et al., 1993). Pathogen-specific, Qa-1-restricted CTL
is expressed only on hematopoietic lineage cells as have been reported in mice after infection with Listeria
compared to expression on epithelial cells in the thy- monocytogenes (Bouwer et al., 1994, 1997; Seaman et
mus. Our findings suggest that there is a dedicated al., 1999), although the class Ib-restricted response in
population of Qa-1-restricted T cells that are selected B6 mice appears to be predominantly H2-M3-restricted
by interaction with Qa-1 and that the cellular require- (Seaman et al., 2000). Qa-1-restricted CTL with specific-
ments for selection may differ from conventional T ity for Salmonella typhimurium have also been reported
cells. (Lo et al., 1999, 2000). Presentation of bacterial antigen
requires TAP function (Bouwer et al., 1997; Lo et al.,
1999). The epitopes in L. monocytogenes recognized byIntroduction
Qa-1-restricted T cells remain to be identified, but a
nonameric peptide from S. typhimurium GroEL has re-The T23-encoded MHC class Ib molecule Qa-1 functions
cently been characterized (Lo et al., 2000). T cells within both innate and adaptive immune responses. The
this specificity crossreact with a peptide from a mousetissue distribution of Qa-1 is similar to classical MHC
heat shock protein, suggesting a possible role in autoim-class Ia molecules, but the level of expression is rela-
munity (Lo et al., 2000). A number of recent studies havetively low, and there is limited polymorphism in mice.
implicated Qa-1 as a restriction element for regulatoryLike class Ia molecules, Qa-1 heavy chain assembles
T cells. Jiang and Chess (2000) have reported the induc-with 2m and peptide, and the complex is transported
tion of Qa-1-restricted CD8 T cells that recognize TCRto the cell surface. However, Qa-1 molecules are pre-
V-derived peptides presented by CD4 T cells anddominantly loaded with a single nonameric peptide,
kill V8CD4 T cells. In addition, recognition of Qa-1Qdm (Qa-1 determinant modifier), derived from the
expressed on B cells by suppressor CD8 T cells hasleader sequence of H-2D/L molecules (Aldrich et al.,
been suggested to play a role in the regulation of anti-1994; Cotterill et al., 1997; DeCloux et al., 1997). Based
body responses (Noble et al., 1998) as well as ocularon in vitro folding and elution experiments with synthetic
anterior chamber-associated immune deviation (D’Ora-
peptide libraries, Qdm has an ideal sequence for binding
zio et al., 2001). The cumulative evidence suggests that
Qa-1b (Kraft et al., 2000). Nevertheless, Qa-1 can bind
Qa-1 might play a special role in regulating both innate
other peptides and present them to T cells. Presentation and adaptive immune responses
of Qdm is strictly dependent on TAP, despite its localiza- Apart from the examples cited above, very little is
tion in a signal peptide (Aldrich et al., 1994; Bai et al., known about T cells with specificity for Qa-1. It is not
1998). However, surface Qa-1 expression is only partially known whether they develop in the thymus like conven-
reduced in lymphoblasts from TAP-deficient mice and tional T cells or whether they are selected by interaction
very high levels of Qa-1 are expressed on TAP-deficient with Qa-1 as opposed to selection by interactions with
T2 cell transfectants (Robinson et al., 1998; Sivakumar more abundant classical class I molecules resulting in
et al., 1999; Vance et al., 1998). The peptides that substi- a subpopulation that crossreacts with Qa-1. It remains
to be determined whether T cells with specificity for Qa-1
arise through an alternative developmental pathway and3 Correspondence: e-mail: pjensen@emory.edu
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whether these cells have functional activities distinct expression levels were slightly reduced as compared to
T cells from control B6 mice. T cells from 6C5 transgenicfrom conventional CD8 T cells. To address these is-
sues, we generated transgenic mice expressing a TCR mice have a naive phenotype (CD44lo, L-selectin,
CD25, CD69), express CD8, and are negative forisolated from a Qa-1b-restricted T cell hybridoma (6C5)
specific for insulin B chain. H-2b mice are low responders expression of Qa-1-specific CD94/NKG2 signaling re-
ceptors (data not shown). Thus, T cells expressing theto pork insulin, generating little or no antibody after
immunization with this antigen (Keck, 1975). However, 6C5 TCR differentiate into CD8 T cells, and there is
no evidence that these cells have been activated byQa-1b-restricted T cell hybridomas can be reproducibly
isolated from H-2b mice immunized with pork insulin endogenous ligands in the periphery. The CD4CD8
phenotype of some previously characterized insulin-(Tompkins et al., 1998). These CD4-negative TCR  T
hybridomas recognize soluble insulin processed and specific, Qa-1-restricted T cell hybridomas generated
with a CD8-negative BW5147 fusion partner (Tompkinspresented through a novel TAP-independent exogenous
antigen presentation pathway that is sensitive to chlo- et al., 1998) can be explained by extinction of CD8 ex-
pression following fusion of CD8 T cells (Carbone etroquine (Tompkins et al., 1998). CD8 is expressed on
those hybridomas that were generated using a CD8- al., 1988).
T cells from 6C5 mice were observed to proliferate inexpressing fusion partner, and antibody-blocking ex-
periments show that CD8 can act as a coreceptor for response to primary in vitro stimulation with soluble
insulin (Figure 1B). Spleen cells from B6 mice but notrecognition of insulin presented by Qa-1. The phenotype
and function of the primary T cells from which these 2m-deficient mice were able to present insulin to nylon
wool enriched 6C5 TCR transgenic T cells (Figure 1C).hybridomas are derived have not been determined. It
is possible that they play a role in regulating immune The residual T cell response observed in the absence
of splenic APC can be attributed to contaminating APCresponses to insulin. In addition, the precise determi-
nant that is presented by Qa-1b remains somewhat of a in the 6C5 T cell preparation or a potential capacity of
the transgenic T cells to present insulin to each other.mystery. Experiments with truncated peptides suggest
that all or most of the 30 amino acid B chain are required. Spleen cells from T region congenic B6.Tlaa mice (ex-
pressing the Qa-1a allele) were unable to present insulinWe report here that expression of TCR genes isolated
from one of these hybridomas is sufficient to confer to 6C5 T cells, demonstrating a requirement for Qa-1b.
However, TAP function was not required. Spleen cellsspecificity for insulin and Qa-1b. There is no evidence
for a role for CD94/NKG2 receptors in this system. Pe- from TAP/ mice presented insulin with efficiency simi-
lar to TAP/ B6 APC (Figure 1C), despite a partial reduc-ripheral T cells from 6C5 TCR transgenic mice express
CD8 and, after activation, efficiently kill Qa-1b-express- tion in the level of expression of Qa-1 on cells from TAP-
deficient mice. These results formally demonstrate thating lymphoid target cells in the presence of intact exoge-
nous soluble insulin. Development of the transgene- transfer of the  TCR is sufficient to confer specificity
for insulin and Qa-1b and that soluble insulin is presentedexpressing T cells occurs in the thymus, and positive
selection requires interaction with Qa-1b. However, the by Qa-1b through a TAP-independent pathway.
Activated T cells from 6C5 transgenic mice kill Qa-1b-dominant peptide bound to Qa-1, Qdm, is not required
for selection. The cellular requirements for thymic selec- expressing T2 target cells in the presence but not the
absence of soluble insulin in a standard 4 hr 51Cr releasetion appear to be different from those of conventional
T cells because efficient selection can be mediated by assay (Figure 1D). Control T2 cells expressing IAb instead
of Qa-1b were not killed. The human T2 lymphoblastoidinteraction with Qa-1b expressed on hematopoietic lin-
eage cells in the thymus. cell line is deficient in TAP, confirming TAP-independent
presentation of soluble insulin to the Qa-1b-restricted
CTL. In addition, 6C5 T cells activated in a 5 day cultureResults
with insulin produce effector cytokines IFN and TNF
but not IL-10 (Figure 1E). IL-4 was also detected byPhenotype and Function of T Cells in 6C5 TCR
intracellular cytokine staining. These results suggestTransgenic Mice
that T cells from 6C5 TCR transgenic mice acquire ef-TCR transgenic mice were generated using a V3.2-
fector functions similar to conventional class Ia-restrictedJ36 TCR  chain and a V5.1-D2-J2.6 TCR  chain
CD8 T cells but they are unusual in their ability tocloned from a T cell hybridoma (6C5) with specificity for
efficiently kill target cells in the presence of exogenousinsulin B chain presented by Qa-1b (Tompkins et al.,
intact protein antigen.1998). This hybridoma was generated with a CD8-
expressing fusion partner, and antibodies to CD8 sub-
stantially block the response to insulin. Thus, CD8 acts Requirements for Selection of T Cells
Bearing the 6C5 TCRas a coreceptor for antigen recognition by the 6C5 TCR.
Studies with two founder lines, backcrossed onto a B6 The role of the thymus in the development of peripheral
T cells expressing the Qa-1b-restricted TCR was investi-background (designated 6C5.B6), demonstrated essen-
tially identical phenotype. Peripheral T cells were gated. Development was severely impaired in thymecto-
mized recipients reconstituted with bone marrow fromstrongly skewed to a CD8 phenotype, with more than
90% of T cells expressing both V3.2 and V5 TCR 6C5 transgenic donors (Figure 2). Very few T cells ex-
pressing the transgenic receptor were detected in thechains on both 6C5.B6-RAG/ and 6C5.B6-RAG/
backgrounds (Figure 1A and data not shown). Con- periphery of thymectomized recipients. Similarly, devel-
opment was blocked after neonatal thymectomy inversely, 95% of splenic V3.2V5 T cells from
6C5.RAG/ mice express CD8. Surface TCR and CD8 6C5 TCR transgenic mice (data not shown). The require-
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Figure 1. Expression of 6C5 T Cell Receptor
Genes and Functional Analysis of Peripheral
Transgenic Cells
(A) Lymph node lymphocytes from C57BL/6
mice and 6C5.RAG/ mice were stained for
CD4, CD8, V3.2, and V5.1 expression.
Numbers indicate the percentage of indi-
cated subpopulations. At least three mice of
each kind were analyzed.
(B) Proliferative response of T cells from 6C5
TCR transgenic mice. Lymphocytes from
C57BL/6 mice and 6C5.B6 TCR transgenic
mice were incubated for 3 days with a dose
range of beef insulin (BINS). Results repre-
sent the mean  SD of counts per min (cpm)
from triplicate cultures.
(C) Qa-1b is required for antigen presentation
to transgenic T cells. Nylon wool enriched T
cells from 6C5.B6 mice were incubated with
irradiated spleen cells from B6, B6.Tlaa,
B6.TAP/, and B6.2m/ mice. Cells were
incubated with a range of BINS, and prolifera-
tion was measured by cell-associated 3H-thy-
midine incorporation in triplicate wells.
(D) Cytotoxic activity of transgenic T cells.
Activated 6C5.B6 T cells were incubated with
T2BB (expressing I-Ab) and T2-g37 (express-
ing Qa-1b) target cells, with or without 1 M
BINS. Effector (E) and Target (T) cells were
mixed at the indicated E:T ratios and incu-
bated for 4 hr in quadruplicate wells. Specific
51Cr release was measured as described in
the Experimental Procedures.
(E) Cytokine production by transgenic T cells.
Spleen cells from 6C5.B6 mice were stimu-
lated with 1 M BINS for 5 days in vitro before
restimulation and intracellular staining. Cells
were stained for CD8 PerCP, V5.1 FITC, and
for the intracellular cytokines IFN, IL-4, IL-
10, or TNF.
ments for thymic selection were further analyzed by Tg/TCR/2m/ bone marrow donors, thus elimi-
generating radiation bone marrow chimeras. TCR nating the potential contribution of endogenous TCR
transgenic mice were crossed with B6.TCR chain chains and mature 6C5 T cells in the donor inoculum.
knockout and B6.2m/ mice to produce 6C5 Selection was monitored by the presence of CD8 sin-
gle-positive thymocytes and CD8V3.2 T cells in
spleens 8–12 weeks after lethal irradiation and reconsti-
tution. The thymic phenotype in 6C5 TCR transgenic
mice and chimeras displayed an unexpectedly low num-
ber of CD8 single-positive thymocytes. Nevertheless,
it is evident that selection occurs in B6 but not 2m/
recipients, as judged by analysis of thymocytes and
peripheral lymphocytes (Figure 3A), demonstrating a re-
quirement for 2m-associated class I molecules. A re-
quirement for Qa-1b was demonstrated by low or absent
selection in T region congenic B6.Tlaa recipients. This
result rules out the possibility that the specificity for Qa-1
represents crossreactivity in cells selected by class Ia
molecules. TAP/ recipients were also unable to sup-
port selection (Figures 3A and 5B), implicating a role
Figure 2. The Thymus Is Required for Development of 6C5 TCR for TAP-dependent peptides in Qa-1b-mediated positive
Transgenic T Cells
selection. It is striking that TAP is required for the devel-
Thymectomized adult mice (Tx) were used as recipients in construc-
opment of T cells expressing the 6C5 TCR but not fortion of bone marrow chimeric mice. Lymphocytes from the spleen
presentation of insulin to these cells. Presentation ofwere analyzed for expression of CD8, V3.2, V5.1, and CD4. These
data represent at least two mice in each group. the dominant Qa-1-associated peptide, Qdm, is depen-
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Figure 3. Positive Selection of 6C5 Transgenic T Cells Requires Qa-1b but Not Qdm
(A) Radiation bone marrow chimeric mice were constructed using 6C5.2m/.TCR/ bone marrow donors and B6, 2m/, B6.Tlaa, TAP/,
or KbDb/ mice recipients. Lymphocytes from the spleen were analyzed for expression of CD8 and V3.2. Numbers represent the percent of
viable lymphocytes. These data represent at least two mice of each type.
(B) Analysis of thymus and spleen cells from 6C5 TCR transgenic mice backcrossed to different genetic backgrounds. Cells from thymus
lobes and spleens of control B6 mice and 6C5 TCR Tg/ mice on the B6, B6.RAG/, B6.2m/, B6.TAP/, and B6.A/ background were
stained with mAbs against CD4, CD8, and V5. Numbers represent the percent of viable lymphocytes. Data represent at least four mice in
each group.
dent on TAP function, raising the possibility that Qdm of a substantial population of TCR TgCD4 T cells in
peripheral lymphoid organs in nonselecting mice (Figuremay mediate selection of 6C5 T cells. Selection was
observed in Kb/Db/ recipients, further supporting the 3B). This probably reflects inefficient MHC class II-medi-
ated selection of T cells coexpressing endogenous TCRconclusion that Qa-1 but not class Ia molecules mediate
selection. However, Db is the only known source of Qdm chains. These CD4 T cells express the transgene-
encoded 6C5 V3.2 and V5 receptor chains, but theypeptide in cells from H-2b mice (Kraft et al., 2000; Sivaku-
mar et al., 1999), and the targeted deletion in Db/ mice respond poorly to insulin, presumably because they do
not express CD8 coreceptor (data not shown). The pos-includes the leader sequence which encodes Qdm (Pas-
colo et al., 1997; Perarnau et al., 1999; Vugmeyster et sibility was considered that expression of transgene-
encoded V5.1 might result in partial negative selectional., 1998). This result strongly suggests that Qdm, the
dominant peptide presented by Qa-1, is not required for mediated by endogenous mammary tumor virus nine
superantigen (Scherer et al., 1993), explaining the un-selection of 6C5 T cells.
The requirement for 2m and TAP was confirmed by usual thymus phenotype in the selecting environment.
This was unlikely given the absence of IE expression inanalysis of 6C5 transgenic mice backcrossed onto
2m/ and TAP/ backgrounds. T cells from these these mice. In addition, there was no change in the
thymic phenotype in 6C5.A/ transgenic mice lackingmice have the potential to express endogenous TCR
genes, although90% express V3.2 and V5. As noted all MHC class II molecules (Figure 3B).
Double-positive thymocytes from 6C5.B6 and Kb-above, an unexpectedly low number of mature single-
positive cells are present in the thymus in the wild- restricted OT-1 TCR transgenic mice are almost uni-
formly CD69hiCD5hi, in contrast to the small fraction oftype B6 background (Figure 3B). However, the thymi of
nonselecting 2m/ and TAP/ mice have a clearly CD69hiCD5hi double-positive thymocytes in nontrans-
genic B6 mice (Figure 4). This is believed to representdistinct profile, with a relatively large population of dou-
ble-positive cells expressing high levels of CD4 and thymocytes receiving signals through TCR ligation and
undergoing selection (Azzam et al., 1998; Swat et al.,CD8. V5CD8 T cells in peripheral lymphoid organs
are essentially absent in 6C5.2m/ mice and substan- 1993; Yamashita et al., 1993). These cells are present
in very low numbers in nonselecting 6C5.2m/ andtially reduced in TAP/ mice. We also note the presence
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Figure 4. Flow Cytofluorometric Analysis of
Thymocytes from 6C5 TCR Tg/ Mice on Se-
lecting and Nonselecting Backgrounds
Cells from thymus lobes of 6C5 TCR Tg/
mice on B6, 2m/, TAP/, and B6.Tlaa back-
grounds and OT1 TCR Tg/ are shown. Cells
were stained for surface expression of CD4,
CD8, and CD5, CD69, or V3.2.
6C5.Tlaa mice. By contrast, double-positive thymocytes can be present in substantial concentrations in serum
and body fluids. We considered the possibility that 2mfrom 6C5.TAP/ express intermediate levels of the
CD69 and CD5 activation markers, despite inefficient derived from hematopoietic cells could complement ex-
pression of Qa-1 on the 2m-deficient cortical thymicselection as shown by very low numbers of TCR-high
double-positive cells and mature single-positive thymo- epithelial cells in 2m/→ 2m/ chimeras. TAP-defi-
cient donors and recipients were used to address thiscytes. This intermediate expression of CD69 and CD5
might be a consequence of weak signals, below the possibility. It is very unlikely that TAP expression on
hematopoietic cells can complement TAP deficiency inthreshold required for positive selection (Wong et al.,
2001), induced by interactions with TAP-independent, thymic epithelial cells. Identical results were obtained
with chimeras generated using TAP-deficient mice. Ex-Qa-1-bound peptides. Alternatively, selecting peptides
may be present but quantitatively reduced below the pression of TAP in either bone marrow or recipient cells
supported efficient selection of peripheral 6C5 T cellsthreshold for selection because of the lower total cell-
surface expression of Qa-1 in TAP-deficient mice. (Figure 5A). This conclusion was also supported by anal-
ysis of thymus. If anything, selection mediated by inter-
action with hematopoietic cells was more efficient than6C5 T Cells Can Be Selected by Either Thymic
that mediated by radioresistant epithelial cells. The func-Epithelial Cells or Hematopoietic Cells
tional capacity of transgenic T cells selected by interac-Given that nothing is known about the cellular require-
tion with hematopoietic cells in the thymus was alsoments for selection of T cells by Qa-1, we investigated
evaluated. A robust proliferative response to insulin waswhether cells expressing the 6C5 TCR can be selected
observed with spleen cells from TAP/→ TAP/ boneby thymic epithelial or hematopoietic cells. Although the
marrow chimeras, similar to chimeras expressing TAPvast majority of T cells are selected by cortical thymic
in both donor and recipient (Figure 5B). By contrast, theepithelial cells (Fink and Bevan, 1995; Fowlkes and
response of spleen cells from control chimeras, in whichSchweighoffer, 1995), NK-T cells are selected by bone
both donor and recipient animals were deficient in TAP,marrow-derived thymocytes expressing the class
was substantially reduced. Thus, it appears that thereI-related molecule, CD1 (Bendelac, 1995; Coles and
is no functional impairment in 6C5 T cells that developRaulet, 2000). Radiation bone marrow chimeras were
through a novel selection pathway, involving interactionconstructed using 6C5.2m/ and 6C5.2m/ donors,
with hematopoietic cells in the thymus.and B6 or B6.2m/ recipients. Selection was evalu-
Qa-1b expression was evaluated by flow cytometry toated by measuring CD8V5 T cells in spleens 7–8
gain some insight into which hematopoietic lineage cellsweeks after transfer. Expression of 2m on either the
might be capable of mediating positive selection. Qa-1bone marrow cells or the radioresistant stromal cells
expression was detected on double-negative cells andwas sufficient to support selection of 6C5 T cells (data
on CD4 and CD8 single-positive cells. By contrast,not shown). No selection was observed in animals lack-
expression was not detected on double-positive thymo-ing 2m and therefore Qa-1 expression on both hemato-
poietic and stromal cells. Noncovalently associated2m cytes (Figure 6A). B cells, NK-T cells, and dendritic cells
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types of donor mice, followed by analysis 6 weeks after
reconstitution. As shown in Figure 7, no selection was
observed in mice reconstituted with a mixture of
6C5.2m/ and B6.2m/ bone marrow. As a positive
control, bone marrow from B6 donors reconstituted se-
lection, as judged by the presence of V3.2V5 single-
positive thymocytes and V5CD8T cells in the periph-
ery. Bone marrow from B cell-deficient MT mice also
reconstituted selection. Most important, selection was
reconstituted with bone marrow cells from TCR/ and
RAG/ donors, demonstrating that double-positive and
single-positive thymocytes are not required for selec-
tion. Together, our results indicate that nonlymphoid
hematopoietic lineage cells or double-negative lymphoid
cells in the thymus are capable of mediated efficient
selection of 6C5 T cells.
Discussion
The results presented in this study represent the first
analysis of the developmental requirements of T cells
with specificity for the nonclassical MHC class I mole-
cule, Qa-1. T cells from the 6C5 transgenic animals al-
most uniformly express transgene-encoded V3.2/V5
TCR and CD8 coreceptor. Based on this, we assume
that the primary T cells from which the 6C5 hybridoma
and other insulin-specific Qa-1-restricted hybridomas
were derived also express CD8. This is consistent with
previous studies demonstrating CD8 expression by Qa-
1-restricted T cells and the observation that CD8 can
act as a coreceptor for recognition of insulin presentedFigure 5. 6C5 TCR Transgenic T Cells Can Be Selected by Hemato-
poietic or Radioresistant Thymic Epithelial Cells and Function Nor- by Qa-1. Qa-1 is the only known ligand for activating
mally and inhibitory CD94/NKG2 receptors (Vance et al., 1998),
(A) Radiation bone marrow chimeric mice were constructed using and these receptors can be expressed on CD8 T cells
6C5.TAP/ or 6C5.TAP/ bone marrow donors and B6 or TAP/ (Lohwasser et al., 2001; Moser et al., 2002). We therefore
mice as recipients. Thymus and spleen cells were stained for CD4, considered the possibility that the interaction between
CD8, and V5 8 weeks after reconstitution. Numbers represent the
Qa-1 and insulin-specific 6C5 T cells might be mediatedpercent of viable lymphocytes. These data represent at least two
through CD94/NKG2 rather than TCR. However, this wasmice in each group from three independent experiments.
ruled out since CD94/NKG2 receptors are not expressed(B) Function of transgenic T cells selected by interaction with Qa-1b
on hematopoietic cells. Spleen cells from chimeric mice were de- on the transgenic T cells. Our results demonstrate that
pleted of CD4 T cells with magnetic beads and cultured for three expression of TCR genes is sufficient to confer specific-
days with a dose range of BINS. Proliferation was measured as ity for both Qa-1b and insulin.
described in the Experimental Procedures.
Experiments with thymectomized mice show that T
cells bearing the 6C5 TCR develop in the thymus. Qa-1b
is required for positive selection. Little or no selection isin the thymus express relatively high levels of Qa-1. The
capacity of sorted populations of thymocytes to present observed in 2m-deficient mice, with markedly reduced
levels of all class I molecules, as well as in T regioninsulin to the 6C5 T cell hybridoma was investigated.
The unsorted population of cells was most efficient in congenic Tlaa mice, which express Qa-1a instead of Qa-
1b. In addition, selection is observed in Kb/Db/ mice,antigen presentation (Figure 6B). This population in-
cluded myeloid lineage cells that had been excluded demonstrating that classical class I molecules are not
required. Thus, it appears that 6C5 T cells may be repre-from the sorted populations, which were gated on
lymphoid cells. The idea that myeloid lineage cells are sentative of a population of T cells that are specifically
selected by interaction with thymic Qa-1 molecules, re-the most potent antigen-presenting cells in the thymus
was further supported by the observation that unsorted taining Qa-1 specificity after maturation. The size of this
population is unknown, but it probably contributes onlythymic cells from RAG-deficient mice were more potent
on a per-cell basis than unsorted cells from B6 mice a small fraction of peripheral CD8 T cells given the
large reduction of CD8 T cells observed in Kb/Db/(Figure 6C). The RAG-deficient thymus is enriched for
nonlymphoid components. mice (Perarnau et al., 1999; Vugmeyster et al., 1998).
The selection requirements for T cells with specificityMixed bone marrow chimeras were generated to iden-
tify hematopoietic lineage cell populations that can me- for another MHC class Ib molecule, H2-M3, have been
investigated using TCR transgenic mice. In two indepen-diate selection. Lethally irradiated TAP-deficient mice
were reconstituted with an equal mixture of 6C5.2m/ dent studies, with H2-M3-restricted TCR specific for
two different Listeria peptides, positive selection wasbone marrow and bone marrow from one of several
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Figure 6. Cell Surface Expression of Qa-1b
and In Vitro Antigen Presentation by Thymic
Subpopulations
(A) Expression of Qa-1b on thymic subpop-
ulations. Gated DN cells (CD4CD8), DP
cells (CD4CD8), CD4 SP cells (CD4CD8),
CD8 SP cells (CD4CD8), NK-T cells
(CD3NK1.1), dendritic cells (CD11cI-Ab),
B cells (CD19), and 	 T cells (	 TCRCD3)
were analyzed for Qa-1b expression (filled his-
tograms) as compared to an isotype control
(open histograms) by flow cytometry.
(B) Antigen presentation by thymic subpopu-
lations. C57BL/6 thymocytes were sorted into
DN (CD4CD8), DP (CD4CD8), CD4 SP
(CD4CD8), and CD8 SP (CD4CD8) cells.
Sorted cells were cultured with 1 M beef
insulin and 6C5 T hybridoma cells.
(C) Thymocytes from C57BL/6 mice, B6.Tlaa,
and B6.RAG/ mice were cultured with 1 M
beef insulin and 6C5 T hybridoma cells. Re-
sults represent IL-2 secretion, mean  SD of
counts per second (cps) from triplicate cul-
tures.
demonstrated to require 2m, TAP, and the wild-type selection. This signaling might be induced by interaction
with a less diverse or alternative repertoire of peptidesH2-M3 allele (Berg et al., 1999; Chiu et al., 1999). Thus,
in all available examples, selection of T cells specific presented by Qa-1 in the absence of TAP (Wong et
al., 2001). Alternatively, it might reflect a quantitativefor nonclassical class I molecules is mediated by the
restricting elements rather than by the more abundantly reduction in the availability of selecting ligand.
From bone marrow chimera experiments, we madeexpressed classical class I molecules.
The peptide(s) mediating positive selection of 6C5 T the surprising observation that 6C5 T cells can be effi-
ciently selected by Qa-1b expressed on hematopoieticcells remain to be defined. Our results strongly suggest
that the dominant peptide presented by Qa-1 molecules, cells in the thymus. Selection was even more efficient
in chimeras expressing Qa-1 solely on hematopoieticQdm, is not required for selection, since selection is
observed in Db/ mice. Db is the only known source of cells as compared to Qa-1 expression on radioresistant
epithelial cells. A hematopoietic cell type has beenQdm in H-2b mice (Kraft et al., 2000; Sivakumar et al.,
1999). Studies on the peptide binding specificity of Qa-1 shown to select NK-T cells, which are specific for the
2m-associated, class I-like molecule CD1 (Bendelac,using synthetic peptide libraries demonstrate that Qa-1b
can bind a diverse array of peptides, yet Qdm has an 1995; Coles and Raulet, 2000). NK-T cells fail to develop
in chimeras reconstituted with 2m-deficient hemato-ideal binding motif (Kraft et al., 2000). Qdm is the only
peptide so far identified in peptide elution studies with poietic stem cells, but normal development is observed
when 2m-deficient hosts are reconstituted with 2mQa-1 purified from cell lines (Cotterill et al., 1997; De-
Cloux et al., 1997). The diversity of peptides presented stem cells. The hematopoietic lineage population re-
sponsible for selection appears to be CD4CD8 thymo-by Qa-1 in vivo remains unknown. Qa-1 expression lev-
els are normal on Qdm-deficient lymphoblastoid cells cytes, and not other cell types, such as thymic dendritic
cells or macrophages. The cellular requirements for se-from Db/ mice (Sivakumar et al., 1999), suggesting that
peptides other than Qdm can support normal expression lection of Qa-1-restricted 6C5 T cells are clearly differ-
ent. Selection can be mediated by either hematopoieticof Qa-1. Selection is markedly reduced in TAP-deficient
mice, implicating a role for TAP-dependent peptide(s) or epithelial cells. Experiments done with mixed bone
marrow chimeras demonstrate that neither double-posi-other than Qdm. It is interesting that selection of 6C5 T
cells is TAP dependent, whereas recognition of insulin tive thymocytes, single-positive thymocytes, nor B cells
are required for selection by hematopoietic cells. Thymicby mature 6C5 T cells is TAP independent. An alternative
possibility is that selection is mediated by TAP-indepen- dendritic cells or macrophages are good candidates for
the hematopoietic lineage cells that mediate selection.dent peptides whose presentation is indirectly reduced
in TAP-deficient cells. Qa-1 expression is reduced in Thymic dendritic cells express relatively high levels of
Qa-1. In addition, sorted thymus lymphoid cells, de-cells from TAP-deficient mice (Robinson et al., 1998;
Sivakumar et al., 1999). The reduced supply of Qa-1 pleted of myeloid components, are relatively inefficient
in presenting insulin to the 6C5 T cell hybridoma. Un-molecules leaving the ER in TAP-deficient cells may limit
the quantity of peptide complexes expressed at the cell sorted hematopoietic cells from RAG-deficient thymus,
enriched for myeloid cells, are considerably more potentsurface generated through peptide-exchange reactions
in post-Golgi compartments (Tompkins et al., 1998). in antigen presentation compared to cells from wild-
type B6 thymus, largely consisting of thymocytes. Nev-Double-positive thymocytes in 6C5.TAP/ mice ex-
press intermediate levels of the activation markers CD69 ertheless, we cannot rule out the possibility that double-
negative thymic lymphoid cells mediate selection of theand CD5, suggesting that they are receiving signals
through the TCR below a threshold required for positive Qa-1-restricted T cells in 6C5 mice.
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hematopoietic stem cells from 2m donors (Bix and
Raulet, 1992). However, the observed selection was very
inefficient compared to selection mediated by class I
expressed on epithelial cells. Ernst et al. reported that
MHC expression on epithelial cells was essential for
positive selection of CD8 or CD4 T cells in thymus
reaggregation cultures (Ernst et al., 1996). In addition,
CD4 T cell development was not observed in MHC
class II-deficient recipients reconstituted with class II
hematopoietic stem cells (Markowitz et al., 1993). These
and many other studies support the conclusion that the
vast majority of conventional T cells are selected by
interaction with MHC molecules expressed on thymic
epithelial cells (Fink and Bevan, 1995; Fowlkes and
Schweighoffer, 1995).
An important caveat in interpreting our results with
Qa-1-specific TCR transgenic mice relates to a report
from Zerrahn et al., who demonstrated that H2-Kb-
restricted 2C TCR transgenic T cells can be selected in
chimeras expressing 2m only on hematopoietic cells
(Zerrahn et al., 1999). No selection of class Ia-restricted
HY TCR transgenic T cells was observed in the same
situation (Kisielow et al., 1988; Zerrahn et al., 1999).
Selection of 2C T cells by MHC on hematopoietic cells
was inefficient, as judged by reduced numbers of mature
TCR clonotype CD8 in thymus (Zerrahn et al., 1999).
In contrast, selection of 6C5 T cells by Qa-1b-positive
hematopoietic cells is at least as efficient as selection by
Qa-1b-positive epithelial cells. Notably, more 2C-TCR
CD8 T cells were observed to develop when 2m-defi-
cient stem cells developed in Kb/Db/ hosts as com-
pared to 2m/ hosts, suggesting that 2C-TCR cells
Figure 7. 6C5 TCR Transgenic T Cells Can Be Positively Selected might be weakly selected by a nonclassical class I mole-
by RAG/ Hematopoietic Cells cule expressed on thymic epithelial cells. The efficiency
Radiation bone marrow chimeric mice were constructed by mixing of selection by nonclassical molecules expressed on
bone marrow from 6C5.2m/ mice and one of the following mice:
hematopoietic lineage cells was not tested. Maurice etB6.2m/, C57BL/6, B6.RAG/, B6.TCR/, or B6.MT. Recipi-
al. recently demonstrated that 2C-TCRCD8 T cellsent mice were B6.TAP/. Thymus and spleen cells were analyzed
develop efficiently in fetal thymic organ culture usingfor expression of CD4, CD8, V3.2, and V5 six weeks after reconsti-
tution. Thymocytes were gated on transgenic cells (V3.2V5). thymic lobes from 2C-TCRKb/Db/ mice but not 2C-
Numbers represent the percent of viable lymphocytes. These data TCR2m/ mice (Maurice et al., 2001). Mature CD8
represent three mice in each group. single-positive thymocytes were present in newborn but
not adult 2CKb/Db/ mice. Thus, some as yet unde-
fined 2m-associated nonclassical class I molecule can
It is tempting to extrapolate from the results presented interact with the 2C TCR and support positive selection,
here and speculate that polyclonal Qa-1-restricted T but only in fetal and newborn animals. It remains to be
cells are efficiently selected by interaction with hemato- determined to what extent nonclassical MHC molecules
poietic lineage cells in the thymus through a develop- contribute to thymic hematopoietic cell-mediated selec-
mental pathway that is distinct from conventional T cells. tion of 2C T cells.
It is generally accepted that the vast majority of CD8 Recent studies have implicated Qa-1 as a restriction
T cells are positively selected through interactions with element for regulatory CD8 T cells (D’Orazio et al.,
cortical epithelial cells in the thymus (Fink and Bevan, 2001; Jiang and Chess, 2000; Noble et al., 1998), raising
1995; Fowlkes and Schweighoffer, 1995). It is possible the question of whether Qa-1 might direct the develop-
that the cellular distribution of Qa-1 or the selecting ment of T cells with specialized function. Activated 6C5
peptide ligand(s) is responsible for the observation that T cells exhibit efficient cytolytic activity, and they ex-
hematopoietic cells can mediate efficient selection. Al- press a cytokine profile similar to conventional CD8 T
ternatively, the low level of expression of Qa-1 as com- cells. Thus, we have no evidence that these cells are
pared to class Ia molecules might increase the range of inherently different with regard to their effector activity.
cell types in the thymus that can present Qa-1-peptide It is striking, however, that activated 6C5 T cells effi-
complexes to developing thymocytes without ex- ciently kill Qa-1b-expressing lymphoblastoid target cells
ceeding the activation threshold that separates positive in the presence of intact exogenous soluble insulin. Insu-
from negative selection. lin is presented by Qa-1 through a novel TAP-indepen-
It is relevant to note that Bix and Raulet demonstrated dent intracellular antigen-processing pathway that is in-
selection of a population of polyclonal CD8 T cells in hibited by the lysosomotropic agent chloroquine and
active in a wide range of cell types (Tompkins et al.,lethally irradiated 2m-deficient mice reconstituted with
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Thymectomy1998). The function of Qa-1-restricted T cells in the con-
Adult mice (6–8 weeks old) were anesthetized with Avertin anesthe-text of polyclonal immune responses to insulin will re-
tic (2% 2,2,2-tribromoethanol, 2% 2-tert-amly alcohol) i.p. Under aquire further investigation. It is conceivable that they
sterile hood, the two thymic lobes were removed. The incision was
might inhibit responses, for example, by killing antigen- clamped together with a surgical staple (Roboz, Gaithersburg, MD).
specific B cells that have processed insulin through Mice were rested for 3 weeks before experimentation. Mock-thy-
mectomized mice were anesthetized and underwent surgery, with-BCR-mediated internalization. Indeed, it is possible that
out the removal of the thymus.the regulatory activity of Qa-1-restricted cytolytic T cells
could in general be related to the ability of Qa-1 to utilize
Radiation Bone Marrow Chimeric Micea specialized peptide-loading pathway that is active in
CD8-depleted bone marrow cells (107 ) were injected intravenously
T cells and B cells. into lethally irradiated (1060 rads) mice. After a 6–8 week recovery,
thymi, lymph nodes (inguinal), and spleens were removed and as-
Experimental Procedures sayed by flow cytometry.
Mice
Flow Cytometry
C57BL/6J mice, 2m/ (B6.129P2-B2mtm1Unc), TCR/ (C57BL/6J-
Single-cell suspensions prepared from freshly isolated thymi, lymph
Tcratm1Mom),MT (B6.129S2-Igh-6tm1Cgn), and RAG/ (C57BL/6J-Rag-
nodes (inguinal), and spleens were incubated with mAb (1:100 dilu-
1tm1Mom) mice, and B6.Tlaa congenic (B6.A-H2-T18a/BoyEg) mice were
tion) for 25–60 min at 4
C. Cells were washed twice, fixed with 1%
purchased from The Jackson Laboratory (Bar Harbor, ME). TAP/
paraformaldehyde, and analyzed by flow cytometry. Fluorescein
mice (B6.129S2-Abcb2tm1Arp) KbDb/ mice (Perarnau et al., 1999),
isothiocyanate (FITC), phycoerythrin (PE), cy-chrome (CyC), peridi-
Db/ mice (Pascolo et al., 1997), A/ mice (Grusby et al., 1991),
nine chlorophyll protein (PerCP), or biotin-conjugated antibodies
and OT-1 mice (Hogquist et al., 1994) have been described pre-
specific for murine CD3 (145-2C11), CD4 (GK1.5), CD5 (53-7.3), CD8
viously. All mice were maintained following institutional guidelines.
(53-6.72), CD11c (HL3), CD19 (1D3), CD24 (M1/69), CD69 (H1.2F3),
NK1.1 (PK136), Qa-1b (6A8.6F10.1A6), 	TCR (GL3), V3.2 (RR3-16),
Cloning of the 6C5 T Cell Receptor and Generation
V5.1/5.2 (MR9-4), IFN (XMG1.2), IL-4 (11B11), IL-10 (JES5-16E3),
of Transgenic Mice
or TNF (MP6-XT22) (Pharmingen, Mountain View, CA) and biotinyl-
The TCR  and  chains of the 6C5 hybridoma were cloned as
ated anti-CD4 (GK1.5) and FITC-labeled anti I-Ab (M5/114) (ATCC,
described (Kraj et al., 2001). The sequences obtained were used to
Manassas, VA) were used in various combinations for flow cytomet-
search the GenBank database. The 6C5-specific TCR is encoded
ric analysis. Biotinylated antibodies were developed with allophyco-
by V3.2-J46/V5.1-D2-J2.6 genes. Based on sequence infor-
cyanin (APC)-conjugated streptavidin (SA) (Molecular Probes, Eu-
mation, we designed primers to amplify and clone the  and  chains
gene, OR). Intracellular staining for cytokines was conducted as
in TCR expression vectors pT and VA-hCD2, respectively (kindly
indicated by the manufacturer (Mouse Intracellular Cytokine Stain-
provided by Drs. D. Mathis and D. Kioussis) (Kouskoff et al., 1995;
ing Kit, Pharmingen, Mountain View, CA). In brief, cells were incu-
Zhumabekov et al., 1995). The 6C5  chain gene was cloned using
bated with beef insulin for 5 hr—the first hr alone and the remaining
the primers 5 (sense) pT-V3.2 (5-TTCCCCGGGCTCAGCCA
4 hr in the presence of brefeldin A (Sigma, St. Louis, MO). Cells
TGCTCCTGGCGCTC-3) and 3 (anti-sense) pT-J36 (5-CACG
were stained with mAb against cell surface proteins, washed, fixed
CGGCCGCGTACCTACCAAGGTTGACCTGAAGTC-3). The 6C5 
and permeabilized, and stained for intracellular cytokines. Fluores-
chain gene was cloned using the primers 5 (sense) VA-V5.1 (5-
cence was analyzed using a FACSCalibur (Becton Dickinson, San
CTCGAATTCTGAGAGGAAGCATGTCTAACAC-3) and 3 (anti-sense)
Diego, CA). Live gates were set on lymphocytes by forward and
VA-C2 (5-GCGAATTCAGGATGCATAAAAGTTTGTCTCAGG-3).
side scatter profiles. Live lymphocytes (50,000–350,000) were col-
TCR transgenic mice were made by comicroinjection of the respec-
lected and then analyzed using CellQuest software (BD Biosciences,
tive TCR and TCR constructs into fertilized eggs of F1 (C57BL/
San Diego, CA). For sorting, a single-cell suspension of thymocytes
6 x C3H/Ca) mice. Two founder mice were generated for the 6C5
from six C57BL/6 mice was washed and stained for expression of
constructs. No significant differences in the phenotypes among the
CD4 and CD8. Cells were sorted from the lymphocyte gate on the
two mouse lines were noticed. In particular, the founders did not
basis of CD4 and CD8 expression on a FACSVantage (Becton Dickin-
differ in the level of TCR expression on thymocyte populations.
son, San Diego, CA) to 97% purity.
Selected founder mice were crossed at least four times with C57BL/
6 mice.
Antigen Presentation Assays with the 6C5 T Hybridoma
6C5 hybridoma cells were cultured with 1 M BINS and varyingProliferation Assays
doses of stimulatory cells, as described in each figure. IL-2 wasIn Figure 1B, splenic lymphocytes were resuspended alone at 5 
measured in the supernatant using a europium-based fluorescence105 cells/200 l in RPMI-C10 supplemented with fetal calf serum.
immunoassay (Jensen et al., 1998), modified for measuring IL-2In Figure 1C, cells were passed over nylon wool to deplete APCs,
using mAb JES6-1A12 and biotinylated JES6-5H4 (Pharmingen,resuspended at 5  105 cells/200 l and cultured with 5  105
Mountain View, CA). IL-2 was measured as fluorescence counts perirradiated spleen cells (1600 rads). In Figure 5C, splenic lymphocytes
second (cps).were depleted of CD4 T cells by magnetic beads. Cells were incu-
bated with varying concentrations of beef insulin (BINS; Elanco
AcknowledgmentsProducts Indianapolis, IN) for 3 days. On the third day of culture,
lymphocytes were pulsed with 3 H-thymidine (1 Ci/well) for 8 hr.
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National Institutes of Health grants AI33614 and AI30554.51Chromium-Release Killing Assay
Splenic lymphocytes were cultured at 3  106 cells/ml with 100
Received: February 13, 2002g/ml BINS and 50 U/ml rIL-2 for 5 days. Cells were then washed
Revised: June 20, 2002and cultured with prepulsed (51Cr) T2BB and T2-g37 cells (Vance et
al., 1998), with or without 1 M BINS. Effector (E) and target (T) cells
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